Astellas’ application to EMA validated for treatment of muscle-invasive bladder cancer
Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer
Read More
Apr 20, 2026 | News, Regulatory
Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer
Read MoreApr 17, 2026 | News, Healthcare
With a 10-day ceasefire between Israel and Lebanon in effect, oil prices are retreating from recent highs
Read MoreApr 17, 2026 | News, Regulatory
The company has been given manufacturing and marketing authorisation for the therapy
Read MoreApr 17, 2026 | News, Healthcare
Spanning four dimensions of skin health, the framework introduces 15 terms and definitions
Read MoreThe agreement covers the development of new lead tau morphomer candidates
Read MoreApr 15, 2026 | News, Healthcare
The scheme supports the development of treatments targeting unmet medical needs in the EU
Read MoreApr 14, 2026 | News, Healthcare
The platform will passively collect data to understand treatment responses in everyday life
Read MoreApr 14, 2026 | News, Healthcare
The collaboration will combine START’s trial network and Trialing’s physician network
Read MoreCreated in 2016, the Standing in the Gaap programme aims to advance more equitable care
Read MoreThe treatment is currently being evaluated in a phase 1/2 multicentre clinical study
Read MoreThe companies aim to advance treatments for narcolepsy and other sleep-wake disorders
Read MoreThe deal will enhance Biogen’s growth portfolio in immunology and rare disease
Read More
